Chemours Co (CC) stock
CCNYSEChemicals & Allied ProductsFiscal year ends December 31
$13.29−0.06 (-0.45%)
Close on Nov 13, 2026Market cap $2.00BP/E –Yield 3.86%
Chemours operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Chemours's operating cash flow for the twelve months ending Sep 30, 2026 was $400.00M, up 50.9% year over year. For fiscal 2025 it was $264.00M. Over ten years it grew 3.8% a year on average. The highest annual figure on record is $1.14B in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $264.00M | – |
| FY2024 | Dec 31, 2024 | -$633.00M | -213.8% |
| FY2023 | Dec 31, 2023 | $556.00M | -26.4% |
| FY2022 | Dec 31, 2022 | $755.00M | -7.2% |
| FY2021 | Dec 31, 2021 | $814.00M | +0.9% |
| FY2020 | Dec 31, 2020 | $807.00M | +24.2% |
| FY2019 | Dec 31, 2019 | $650.00M | -43.0% |
| FY2018 | Dec 31, 2018 | $1.14B | +78.1% |
| FY2017 | Dec 31, 2017 | $640.00M | +7.7% |
| FY2016 | Dec 31, 2016 | $594.00M | +226.4% |
| FY2015 | Dec 31, 2015 | $182.00M | -64.0% |
| FY2014 | Dec 31, 2014 | $505.00M | -36.7% |
| FY2013 | Dec 31, 2013 | $798.00M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $149.00M | +2.1% |
| Q2 FY2026 | Jun 30, 2026 | $158.00M | +69.9% |
| Q1 FY2026 | Mar 31, 2026 | -$44.00M | – |
| Q4 FY2025 | Dec 31, 2025 | $137.00M | -0.7% |
| Q3 FY2025 | Sep 30, 2025 | $146.00M | +5.0% |
| Q2 FY2025 | Jun 30, 2025 | $93.00M | – |
| Q1 FY2025 | Mar 31, 2025 | -$112.00M | – |
| Q4 FY2024 | Dec 31, 2024 | $138.00M | -71.4% |
| Q3 FY2024 | Sep 30, 2024 | $139.00M | +6.1% |
| Q2 FY2024 | Jun 30, 2024 | -$620.00M | -1025.4% |
| Q1 FY2024 | Mar 31, 2024 | -$290.00M | – |
| Q4 FY2023 | Dec 31, 2023 | $482.00M | +199.4% |
| Q3 FY2023 | Sep 30, 2023 | $131.00M | -56.5% |
| Q2 FY2023 | Jun 30, 2023 | $67.00M | -77.0% |
| Q1 FY2023 | Mar 31, 2023 | -$124.00M | -6300.0% |
| Q4 FY2022 | Dec 31, 2022 | $161.00M | -22.6% |
| Q3 FY2022 | Sep 30, 2022 | $301.00M | -3.2% |
| Q2 FY2022 | Jun 30, 2022 | $291.00M | +13.7% |
| Q1 FY2022 | Mar 31, 2022 | $2.00M | -94.9% |
| Q4 FY2021 | Dec 31, 2021 | $208.00M | -41.1% |
| Q3 FY2021 | Sep 30, 2021 | $311.00M | +4.0% |
| Q2 FY2021 | Jun 30, 2021 | $256.00M | +130.6% |
| Q1 FY2021 | Mar 31, 2021 | $39.00M | -11.4% |
| Q4 FY2020 | Dec 31, 2020 | $353.00M | -11.8% |
| Q3 FY2020 | Sep 30, 2020 | $299.00M | +3.8% |
| Q2 FY2020 | Jun 30, 2020 | $111.00M | +1750.0% |
| Q1 FY2020 | Mar 31, 2020 | $44.00M | – |
| Q4 FY2019 | Dec 31, 2019 | $400.00M | +54.4% |
| Q3 FY2019 | Sep 30, 2019 | $288.00M | -15.8% |
| Q2 FY2019 | Jun 30, 2019 | $6.00M | -98.3% |
| Q1 FY2019 | Mar 31, 2019 | -$44.00M | -122.4% |
| Q4 FY2018 | Dec 31, 2018 | $259.00M | -14.5% |
| Q3 FY2018 | Sep 30, 2018 | $342.00M | +205.4% |
| Q2 FY2018 | Jun 30, 2018 | $343.00M | +86.4% |
| Q1 FY2018 | Mar 31, 2018 | $196.00M | +378.0% |
| Q4 FY2017 | Dec 31, 2017 | $303.00M | +12.2% |
| Q3 FY2017 | Sep 30, 2017 | $112.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $184.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $41.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $270.00M | – |
See a number that looks wrong?